US Patent Issued to SUNVAX MRNA THERAPEUTICS on Feb. 17 for "Compositions and methods for delivering molecules" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,451, issued on Feb. 17, was assigned to SUNVAX MRNA THERAPEUTICS INC. (Beverly, Mass.).

"Compositions and methods for delivering molecules" was invented by Yingzhong Li (Reading, Mass.) and Libin Zhang (Lynnfield, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions comprising mRNA, self-amplifying mRNA (sa-mRNA), modified mRNA, or circular RNA constructs comprising a gene-of-interest, and lipids and LNPs for use in therapy are disclosed. A method of delivering a payload to immune cells ex vivo by contacting immune cells with a lipid nanoparticle (LNP) encapsulating a payload encoding at least one polypeptide of interest, wherein the po...